Researcher to be Recognized for Efforts to Better Understand, Treat MS
February 21, 2012
Richard Ransohoff, MD, a Cleveland Clinic physician and a researcher in the Neurosciences Department of Cleveland Clinic’s Lerner Research Institute, has been awarded the 2012 John Dystel Prize for Multiple Sclerosis Research.
The award – presented by the American Academy of Neurology (AAN) and the National Multiple Sclerosis Society since 1995 – is given annually to one recipient, recognizing “outstanding contributions to research in the understanding, treatment, or prevention of multiple sclerosis” and “significant and exciting work that has influenced how we think about multiple sclerosis.”
Dr. Ransohoff's most recent contributions to the field of multiple sclerosis (MS) include the discovery that MS can progress from the outermost layers of the brain to its interior. Aiming to lower the risk/benefit ratio of multiple sclerosis therapy, he has also recently developed an experimental model that allowed his group to identify a novel mechanism for harmful infiltration of white blood cells into the central nervous system. With increased understanding of this process and how it is regulated, new therapeutic targets are possible.
“It is an honor to receive this award, which recognizes the research done by my colleagues and me. With support from the National Institutes of Health, the National MS Society and generous individual donors, this prestigious award inspires our daily work,” Dr. Ransohoff said. “During the past 15 years, we’ve identified several new molecules as potential targets for MS treatments and rationales for developing new MRI techniques to visualize brain damage in MS.”
Dr. Ransohoff will be awarded the prize at the 2012 AAN Annual Meeting in New Orleans. With Dr. Ransohoff and the 2003 recipient, Bruce Trapp, PhD, the chairman of the Neurosciences Department of the Lerner Research Institute, Cleveland Clinic joins Yale University and the University College London as the only institutions with two Dystel Prize awardees.
Cleveland Clinic’s Mellen Center for Multiple Sclerosis Treatment and Research is one of the largest and most comprehensive programs for MS care. Mellen Center physicians are national leaders in basic and clinical research related to MS pathogenesis and medical management and have made major contributions in the development of drugs to control MS disease activity and progression.
About Cleveland Clinic
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. It was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S.News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey. About 2,800 full-time salaried physicians and researchers and 11,000 nurses represent 120 medical specialties and subspecialties. Cleveland Clinic Health System includes a main campus near downtown Cleveland, eight community hospitals and 16 Family Health Centers in Northeast Ohio, Cleveland Clinic Florida, the Lou Ruvo Center for Brain Health in Las Vegas, Cleveland Clinic Canada, and opening in 2013, Cleveland Clinic Abu Dhabi. In 2010, there were 4 million visits throughout the Cleveland Clinic health system and 155,000 hospital admissions. Patients came for treatment from every state and from more than 100 countries. Visit us at www.clevelandclinic.org/. Follow us at www.twitter.com/ClevelandClinic.
Dan Doron, 216.636.5874, email@example.com
Halle Bishop, 216.445.8592, firstname.lastname@example.org